Lonza is a life sciences driven chemical company supplying active chemical ingredients, intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries. 
Lonza will focus on the implementation of its growth strategy which includes key areas such as operational, technical and leadership, innovation, and commercial performance.
It will implement its strategy by focusing on vigorous internal organic growth and permanently adjusting its portfolio of chemical and biotechnology businesses.
Realignment and growth in defined life-science markets are primary objectives. In addition, the company will focus on the integration of the acquired Genetech’s mammalian cell culture facility in Porrino, Spain, and Cambrex’s microbial biopharmaceuticals business.
Its strategy includes focusing on the manufacture of active pharmaceutical ingredients and vitamins and building up its research and development capability.
Lonza is headquartered in Basel, Switzerland, with sales of SF2.9bn in 2008 and employs around 8,462 people worldwide.
ICIS Chemical Business magazine has unveiled the ICIS Top 100 Chemical Companies, with rankings based on 2008 sales.
A PDF of the ICIS Top 100 Chemical Companies is available for download on ICIS connect.
See the article and analysis of the ICIS Top 100 on ICIS news.
Key Personnel
Board members
Chairman: Rolf Soiron
Vice chairman: Richard Sykes
Member of the board: Patrick Aebischer
Member of the board: Julia Higgins
Member of the board: Frits van Dijk
Member of the board: Gerhard Mayr
Member of the board: Peter Wilden
Members of the management committee
Chief executive officer: Stefan Borgas
Chief financial officer: Toralf Haag
Joint head (custom manufacturing): Uwe Boehlke
Joint head (custom manufacturing): Stephan Kutzer
Head (bioscience): Anja Fiedler
Head (life science): Lukas Utiger
Head (performance chemicals): Jeanne Thoma
Contacts
Lonza Group
Munchenstienerstrasse 38
PO Box
CH-4002 Basel
Switzerland
Tel: +41 61 316 8111
Fax: +41 61 316 9111
www.lonza.com/group/en
Lonza
Company Structure
Lonza is a life sciences driven chemical company. Lonza was formed when the chemical activities were demerged from parent company Algroup, in October 1999. In the past century, Lonza has developed from a carbide and fertiliser plant into a specialised, globally operating chemical and biotechnology company.
More about Lonza Structure
Lonza
Strategy & Financial Highlights
Lonza will focus on the implementation of its growth strategy. This is based on a plan that was created over two years ago and has been regularly updated and improved. The key points of this strategy include key areas such as operational, technical and leadership, innovation, and commercial performance. (Edited from: “Letter to shareholders). ICIS also provides you with key financial data listed in table form.
More about Lonza Strategy & Financial Highlights
News:
Get news on Lonza plus the latest chemical news, information, data, market movements and analysis
in one place with ICIS news
Search:
Find details on other chemical companies and suppliers with
ICIS search
Newsletters:
ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.
Plants and projects:
Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database